Foreign-Trade Zone (FTZ) 93-Raleigh/Durham, North Carolina; Notification of Proposed Production Activity; Liebel-Flarsheim Company, LLC (Diagnostic Imaging Contrast Media); Raleigh, North Carolina, 37116 [2021-14955]

Download as PDF 37116 Federal Register / Vol. 86, No. 132 / Wednesday, July 14, 2021 / Notices DEPARTMENT OF COMMERCE Foreign-Trade Zones Board [B–21–2021] Foreign-Trade Zone (FTZ) 99— Wilmington, Delaware; Authorization of Production Activity; AstraZeneca Pharmaceuticals LP (Pharmaceutical Products); Newark, Delaware On March 11, 2021, AstraZeneca Pharmaceuticals LP submitted a notification of proposed production activity to the FTZ Board for its facility within Subzone 99D, in Newark, Delaware. The notification was processed in accordance with the regulations of the FTZ Board (15 CFR part 400), including notice in the Federal Register inviting public comment (86 FR 14867–14868, March 19, 2021). On July 9, 2021, the applicant was notified of the FTZ Board’s decision that no further review of the activity is warranted at this time. The production activity described in the notification was authorized, subject to the FTZ Act and the FTZ Board’s regulations, including Section 400.14. Dated: July 9, 2021. Andrew McGilvray, Executive Secretary. [FR Doc. 2021–14958 Filed 7–13–21; 8:45 am] BILLING CODE 3510–DS–P DEPARTMENT OF COMMERCE Foreign-Trade Zones Board [B–53–2021] lotter on DSK11XQN23PROD with NOTICES1 Foreign-Trade Zone (FTZ) 93—Raleigh/ Durham, North Carolina; Notification of Proposed Production Activity; LiebelFlarsheim Company, LLC (Diagnostic Imaging Contrast Media); Raleigh, North Carolina The Triangle J Council of Governments, grantee of FTZ 93, submitted a notification of proposed production activity to the FTZ Board on behalf of Liebel-Flarsheim Company, LLC (Liebel-Flarsheim), located in Raleigh, North Carolina. The notification conforming to the requirements of the regulations of the FTZ Board (15 CFR 400.22) was received on June 30, 2021. Liebel-Flarsheim already has authority to produce diagnostic imaging contrast media within FTZ 93. The current request would add a finished product and a foreign status material to the scope of authority. Pursuant to 15 CFR 400.14(b), additional FTZ authority would be limited to the specific foreign- VerDate Sep<11>2014 17:49 Jul 13, 2021 Jkt 253001 status material and specific finished product described in the submitted notification (as described below) and subsequently authorized by the FTZ Board. Production under FTZ procedures could exempt Liebel-Flarsheim from customs duty payments on the foreignstatus material used in export production. On its domestic sales, for the foreign-status materials noted below and in the existing scope of authority, Liebel-Flarsheim would be able to choose the duty rate during customs entry procedures that applies to gadopiclenol (finished contrast media) (duty-free). Liebel-Flarsheim would be able to avoid duty on the foreign-status material which becomes scrap/waste. Customs duties also could possibly be deferred or reduced on foreign-status production equipment. The material sourced from abroad is gadopiclenol (active pharmaceutical ingredient) (duty rate—3.7%). The request indicates that the material is subject to duties under Section 301 of the Trade Act of 1974 (Section 301), depending on the country of origin. The applicable Section 301 decisions require subject merchandise to be admitted to FTZs in privileged foreign status (19 CFR 146.41). Public comment is invited from interested parties. Submissions shall be addressed to the Board’s Executive Secretary and sent to: ftz@trade.gov. The closing period for their receipt is August 23, 2021. A copy of the notification will be available for public inspection in the ‘‘Reading Room’’ section of the Board’s website, which is accessible via www.trade.gov/ftz. For further information, contact Diane Finver at Diane.Finver@trade.gov. Dated: July 8, 2021. Andrew McGilvray, Executive Secretary. [FR Doc. 2021–14955 Filed 7–13–21; 8:45 am] BILLING CODE 3510–DS–P DEPARTMENT OF COMMERCE Foreign-Trade Zones Board [S–78–2021] Approval of Subzone Status; Watco Transloading, LLC; Parsons, Kansas On May 18, 2021, the Executive Secretary of the Foreign-Trade Zones (FTZ) Board docketed an application submitted by the Board of County Commissioners of Sedgwick County, grantee of FTZ 161, requesting subzone status subject to the existing activation PO 00000 Frm 00003 Fmt 4703 Sfmt 4703 limit of FTZ 161, on behalf of Watco Transloading, LLC, in Parsons, Kansas. The application was processed in accordance with the FTZ Act and Regulations, including notice in the Federal Register inviting public comment (86 FR 27827, May 24, 2021). The FTZ staff examiner reviewed the application and determined that it meets the criteria for approval. Pursuant to the authority delegated to the FTZ Board Executive Secretary (15 CFR 400.36(f)), the application to establish Subzone 161D was approved on July 8, 2021, subject to the FTZ Act and the Board’s regulations, including Section 400.13, and further subject to FTZ 161’s 2,000-acre activation limit. Dated: July 8, 2021. Andrew McGilvray, Executive Secretary. [FR Doc. 2021–14956 Filed 7–13–21; 8:45 am] BILLING CODE 3510–DS–P DEPARTMENT OF COMMERCE Foreign-Trade Zones Board [B–52–2021] Foreign-Trade Zone (FTZ) 265— Conroe, Texas; Notification of Proposed Production Activity; Galdisa USA (Peanut Products); Conroe, Texas The City of Conroe, Texas, grantee of FTZ 265, submitted a notification of proposed production activity to the FTZ Board on behalf of Galdisa USA (Galdisa), located in Conroe, Texas. The notification conforming to the requirements of the regulations of the FTZ Board (15 CFR 400.22) was received on June 30, 2021. The Galdisa facility is located within FTZ 265. The facility is used for the production of peanut products. Galdisa is requesting export-only FTZ authority to produce peanut butter, roasted peanuts, peanut granules, peanut paste, and blanched peanuts. Pursuant to 15 CFR 400.14(b), FTZ activity would be limited to the specific foreign-status materials and specific finished products described in the submitted notification (as described below) and subsequently authorized by the FTZ Board. Production under FTZ procedures could exempt Galdisa from customs duty payments on the foreign-status components used in the company’s export production of peanut products. Customs duties also could possibly be deferred or reduced on foreign-status production equipment. If the proposal were approved, the foreign-status sugar and peanuts used in the FTZ production for export would not be subject to quota(s). E:\FR\FM\14JYN1.SGM 14JYN1

Agencies

[Federal Register Volume 86, Number 132 (Wednesday, July 14, 2021)]
[Notices]
[Page 37116]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-14955]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-53-2021]


Foreign-Trade Zone (FTZ) 93--Raleigh/Durham, North Carolina; 
Notification of Proposed Production Activity; Liebel-Flarsheim Company, 
LLC (Diagnostic Imaging Contrast Media); Raleigh, North Carolina

    The Triangle J Council of Governments, grantee of FTZ 93, submitted 
a notification of proposed production activity to the FTZ Board on 
behalf of Liebel-Flarsheim Company, LLC (Liebel-Flarsheim), located in 
Raleigh, North Carolina. The notification conforming to the 
requirements of the regulations of the FTZ Board (15 CFR 400.22) was 
received on June 30, 2021.
    Liebel-Flarsheim already has authority to produce diagnostic 
imaging contrast media within FTZ 93. The current request would add a 
finished product and a foreign status material to the scope of 
authority. Pursuant to 15 CFR 400.14(b), additional FTZ authority would 
be limited to the specific foreign-status material and specific 
finished product described in the submitted notification (as described 
below) and subsequently authorized by the FTZ Board.
    Production under FTZ procedures could exempt Liebel-Flarsheim from 
customs duty payments on the foreign-status material used in export 
production. On its domestic sales, for the foreign-status materials 
noted below and in the existing scope of authority, Liebel-Flarsheim 
would be able to choose the duty rate during customs entry procedures 
that applies to gadopiclenol (finished contrast media) (duty-free). 
Liebel-Flarsheim would be able to avoid duty on the foreign-status 
material which becomes scrap/waste. Customs duties also could possibly 
be deferred or reduced on foreign-status production equipment.
    The material sourced from abroad is gadopiclenol (active 
pharmaceutical ingredient) (duty rate--3.7%). The request indicates 
that the material is subject to duties under Section 301 of the Trade 
Act of 1974 (Section 301), depending on the country of origin. The 
applicable Section 301 decisions require subject merchandise to be 
admitted to FTZs in privileged foreign status (19 CFR 146.41).
    Public comment is invited from interested parties. Submissions 
shall be addressed to the Board's Executive Secretary and sent to: 
[email protected]. The closing period for their receipt is August 23, 2021.
    A copy of the notification will be available for public inspection 
in the ``Reading Room'' section of the Board's website, which is 
accessible via www.trade.gov/ftz.
    For further information, contact Diane Finver at 
[email protected].

    Dated: July 8, 2021.
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2021-14955 Filed 7-13-21; 8:45 am]
BILLING CODE 3510-DS-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.